SEARCH

SEARCH BY CITATION

References

  • Al Dieri, R., Peyvandi, F., Santagostino, E., Giansily, M., Mannucci, P.M., Schved, J.F., Beguin, S. & Hemker, H.C. (2002) The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding. Thrombosis and Haemostasis, 88, 576582.
  • Amaral, A., Opal, S.M. & Vincent, J.-L. (2004) Coagulation in sepsis. Intensive Care Medicine, 30, 10321040.
  • American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Critical Care Medicine, 20, 864874.
  • American Society of Anesthesiologists Task Force on Blood Component Therapy (1996) Practice guidelines for blood component therapy: a report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology, 84, 732747.
  • Braun, P., Givens, T.B., Stead, A.G., Beck, L.R., Gooch, S.A., Swan, R.J. & Fischer, T.J. (1997) Properties of optical data from activated partial thromboplastin time and prothrombin time assays. Thrombosis and Haemostasis, 78, 10791087.
  • Chowdhury, P., Saayman, A.G., Paulus, U., Findlay, G.P. & Collins, P.W. (2004) Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. British Journal of Haematology, 125, 6973.
  • Dempfle, C.-E. (2004) Coagulopathy of sepsis. Thrombosis and Haemostasis, 91, 213224.
  • Dhainaut, J.F., Shorr, A.F., Macias, W.L., Kollef, M.J., Levi, M., Reinhart, K. & Nelson, D.R. (2005) Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure. Critical Care Medicine, 33, 341348.
  • Dixon, B. (2004) The role of microvascular thrombosis in sepsis. Anaesthesia and Intensive Care, 32, 619629.
  • Gando, S., Nanzaki, S., Sasaki, S., Aoi, K. & Kemmotsu, O. (1998) Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock. Critical Care Medicine, 26, 20052009.
  • Hemker, H.C., Giesen, P., Al Dieri, R., Regnault, V., De Smedt, E., Wagenvoord, R., Lecompte, T. & Béguin, S. (2003) Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiology of Haemostasis and Thrombosis, 33, 415.
  • Hesselvik, J.F., Blomback, M., Brodin, B. & Maller, R. (1989) Coagulation, fibrinolysis, and kallikrein systems in sepsis: relation to outcome. Critical Care Medicine, 17, 724733.
  • Levi, M., Keller, T.T., Van Gorp, E., Ten Cate, H. (2003) Infection and inflammation and the coagulation system. Cardiovascular Research, 60, 2639.
  • Luddington, R. & Baglin, T. (2004) Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition. Journal of Thrombosis and Haemostasis, 11, 19541959.
  • Mann, K.G., Brummel, K. & Butenas, S. (2003) What is all the thrombin for? Journal of Thrombosis and Haemostasis, 1, 15041514.
  • Mannucci, P.M. (2006) Abnormal haemostasis tests and bleeding in chronic liver disease: are they related? No. Journal of Thrombosis and Haemostasis, 4, 721723.
  • Mavrommatis, A.C., Theodoridis, T., Orfanidou, A., Roussos, C., Christopoulou-Kokkinou, V. & Zakynthinos, S. (2000) Coagulation system and platelets are fully activated in uncomplicated sepsis. Critical Care Medicine, 28, 451457.
  • Niessen, R.W., Lamping, R.J., Jansen, P.M., Prins, M.H., Peters, M., Taylor, F.B. Jr, De Vijlder, J.J., Ten Cate, J.W., Hack, C.E. & Sturk, A. (1997) Antithrombin acts as a negative acute phase protein as established with studies on HepG2 cells and in baboons. Thrombosis and Haemostasis, 78, 10881092.
  • Reverter, J.C. (2006) Abnormal haemostasis tests and bleeding in chronic liver disease: are they related? Yes. Journal of Thrombosis and Haemostasis, 4, 717720.
  • Roberts, H.R., Monroe, D.M. & Escobar, M.A. (2004) Current concepts of hemostasis: implications for therapy. Anesthesiology, 100, 722730.
  • Segal, J.B. & Dzik, W.H. (2005) Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion, 45, 14131425.
  • Sorensen, B., Johansen, P., Christiansen, K., Woelke, M. & Ingerslev, J. (2003) Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation. Journal of Thrombosis and Haemostasis, 1, 551558.
  • Taylor, F.B. Jr, Chang, A., Ruf, W., Morrissey, J.H., Hinshaw, L., Catlett, R., Blick, K. & Edgington, T.S. (1991) Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circulatory Shock, 33, 127134.
  • Toh, C.H., Ticknor, L.O., Downey, C., Giles, A.R., Paton, R.C. & Wenstone, R. (2003) Early identification of sepsis and mortality risks through simple, rapid clot-waveform analysis. Implications of lipoprotein-complexed C reactive protein formation. Intensive Care Medicine, 29, 5561.